Physician profile
Joshua Calvert
NPI 1629424585
$22,997.43
in general payments reported to CMS, 2019-2025
32 companies · $13K in 2025
The $13K reported for 2025 was more than what 95% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,685 · 2022: $2,330 · 2023: $3,028 · 2024: $3,236 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $5,405 · Travel and Lodging: $2,176 · Education: $3.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,397.91 |
| Food and Beverage | $5,405.11 |
| Travel and Lodging | $2,175.97 |
| Education | $3.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $7,209.78 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Tolmar, INC. | $5,933.99 | 2023-2025 | Jatenzo, Eligard |
| Boston Scientific Corporation | $4,946.98 | 2021-2025 | Ams 700 Cxr Rte Kit, Ams 700, General - Erectile Dysfunction |
| Coloplast Corp | $2,142.96 | 2021-2025 | Titan, Porges Coloplast |
| Sumitomo Pharma America, INC. | $480.02 | 2023-2025 | Gemtesa, Orgovyx |
| Innovation Technologies INC | $244.73 | 2023-2024 | Irrisept |
| Halozyme INC | $216.66 | 2023 | |
| Srs Medical Systems, INC. | $197.00 | 2024 | Urocuff-Dc Disposable, Single, Ct3000 Pro Base Unit |
| Olympus America INC. | $187.05 | 2025 | Itind System |
| Medtronic, INC. | $158.08 | 2021-2024 | Interstim |
| Antares Pharma, INC. | $136.36 | 2024 | Xyosted |
| Merck Sharp & Dohme LLC | $130.59 | 2022-2024 | Welireg, Keytruda |
| Janssen Biotech, INC. | $123.78 | 2021 | |
| Astellas Pharma US INC | $119.31 | 2022 | |
| Endo Pharmaceuticals INC. | $117.02 | 2023 | Xiaflex |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $81.80 | 2023-2025 | Botox |
| Teleflex LLC | $72.29 | 2024 | Urolift |
| Laborie Medical Technologies Corp. | $65.24 | 2023-2025 | Urgent Pc Neuromodulation System, Optilume Bph Drug Coated Balloon Catheter |
| Verity Pharmaceuticals INC. | $57.91 | 2023-2024 | Tlando, Trelstar |
| Urogen Pharma, INC. | $43.31 | 2024-2025 | |
| Agiliti Health, INC. | $42.73 | 2023 | Soltive, Versapulse Powersuite 80w, Sonablate |
| Acerus Pharmaceuticals Corporation | $42.26 | 2022 | |
| Pfizer INC. | $37.28 | 2023-2024 | |
| Urovant Sciences INC | $36.44 | 2022 | |
| Azurity Pharmaceuticals, INC. | $35.26 | 2025 | Azmiro |
| Axonics, INC. | $24.42 | 2023 | Axonics, Bulkamid |
| Sun Pharmaceutical Industries INC. | $24.30 | 2024 | |
| Dendreon Pharmaceuticals LLC | $24.01 | 2024 | Provenge |
| Ferring Pharmaceuticals INC. | $23.37 | 2024 | Adstiladrin |
| Endo USA, INC. | $16.23 | 2024 | Xiaflex |
| Astrazeneca Pharmaceuticals Lp | $14.43 | 2023 | Lynparza |
| Myovant Sciences INC. | $11.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Calvert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.